JP2005281314A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005281314A5 JP2005281314A5 JP2005135218A JP2005135218A JP2005281314A5 JP 2005281314 A5 JP2005281314 A5 JP 2005281314A5 JP 2005135218 A JP2005135218 A JP 2005135218A JP 2005135218 A JP2005135218 A JP 2005135218A JP 2005281314 A5 JP2005281314 A5 JP 2005281314A5
- Authority
- JP
- Japan
- Prior art keywords
- parenteral
- present
- preparation according
- parenteral preparation
- dihydrocarbamazepine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000009472 formulation Methods 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 206010019196 Head injury Diseases 0.000 claims description 3
- 239000001961 anticonvulsive agent Substances 0.000 claims description 3
- 208000026106 cerebrovascular disease Diseases 0.000 claims description 3
- 206010010904 Convulsion Diseases 0.000 claims description 2
- 208000029650 alcohol withdrawal Diseases 0.000 claims description 2
- 230000001773 anti-convulsant effect Effects 0.000 claims description 2
- 229960003965 antiepileptics Drugs 0.000 claims description 2
- 230000000977 initiatory effect Effects 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 4
- 239000008103 glucose Substances 0.000 claims 4
- BMPDWHIDQYTSHX-UHFFFAOYSA-N licarbazepine Chemical compound C1C(O)C2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 BMPDWHIDQYTSHX-UHFFFAOYSA-N 0.000 claims 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 230000001037 epileptic effect Effects 0.000 claims 1
- 208000014617 hemorrhoid Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 206010015037 epilepsy Diseases 0.000 description 2
- 208000005809 status epilepticus Diseases 0.000 description 2
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 229940125681 anticonvulsant agent Drugs 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9721497.7A GB9721497D0 (en) | 1997-10-09 | 1997-10-09 | Organic compounds |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000515601A Division JP2001519395A (ja) | 1997-10-09 | 1998-10-07 | カルバマゼピンまたはその誘導体を含む非経口製剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005281314A JP2005281314A (ja) | 2005-10-13 |
| JP2005281314A5 true JP2005281314A5 (https=) | 2009-03-19 |
Family
ID=10820342
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000515601A Withdrawn JP2001519395A (ja) | 1997-10-09 | 1998-10-07 | カルバマゼピンまたはその誘導体を含む非経口製剤 |
| JP2005135218A Pending JP2005281314A (ja) | 1997-10-09 | 2005-05-06 | カルバマゼピンまたはその誘導体を含む非経口製剤 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000515601A Withdrawn JP2001519395A (ja) | 1997-10-09 | 1998-10-07 | カルバマゼピンまたはその誘導体を含む非経口製剤 |
Country Status (31)
| Country | Link |
|---|---|
| US (2) | US6316417B1 (https=) |
| EP (1) | EP1033988B1 (https=) |
| JP (2) | JP2001519395A (https=) |
| KR (1) | KR100760326B1 (https=) |
| CN (1) | CN1210032C (https=) |
| AR (1) | AR015465A1 (https=) |
| AT (1) | ATE257383T1 (https=) |
| AU (1) | AU748034B2 (https=) |
| BR (1) | BR9812861A (https=) |
| CA (1) | CA2304661C (https=) |
| CO (2) | CO4950520A1 (https=) |
| CZ (1) | CZ298900B6 (https=) |
| DE (1) | DE69821024T2 (https=) |
| DK (1) | DK1033988T3 (https=) |
| ES (1) | ES2214738T3 (https=) |
| GB (1) | GB9721497D0 (https=) |
| HU (1) | HU226106B1 (https=) |
| ID (1) | ID24134A (https=) |
| IL (1) | IL135123A0 (https=) |
| MY (1) | MY122129A (https=) |
| NO (1) | NO327263B1 (https=) |
| NZ (1) | NZ503526A (https=) |
| PE (1) | PE121998A1 (https=) |
| PL (1) | PL192287B1 (https=) |
| PT (1) | PT1033988E (https=) |
| RU (1) | RU2242231C2 (https=) |
| SK (1) | SK286253B6 (https=) |
| TR (1) | TR200000870T2 (https=) |
| TW (1) | TW584563B (https=) |
| WO (1) | WO1999018966A1 (https=) |
| ZA (1) | ZA989183B (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0507298D0 (en) | 2005-04-11 | 2005-05-18 | Novartis Ag | Organic compounds |
| US20100204178A1 (en) | 2006-10-02 | 2010-08-12 | James Cloyd | Novel parenteral carbamazepine formulation |
| PT1928464E (pt) * | 2005-09-30 | 2014-07-10 | Lundbeck Inc | Nova formulação parentérica de carbamazepina |
| WO2007092620A2 (en) * | 2006-02-09 | 2007-08-16 | Macusight, Inc. | Stable formulations, and methods of their preparation and use |
| US8372431B2 (en) * | 2007-10-26 | 2013-02-12 | Bial-Portela & C.A., S.A. | Pharmaceutical composition comprising licarbazepine acetate |
| CN101711739B (zh) * | 2008-10-08 | 2012-07-04 | 中国人民解放军军事医学科学院毒物药物研究所 | 卡马西平的口服药物组合物 |
| CN105726466A (zh) * | 2014-12-10 | 2016-07-06 | 辽宁药联制药有限公司 | 一种奥卡西平注射剂及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5202311A (en) * | 1988-08-19 | 1993-04-13 | Children's Medical Center Corporation | Stabilized fgf composition |
| ATE133079T1 (de) * | 1989-12-27 | 1996-02-15 | Ciba Geigy Ag | Vorrichtung zum homogenisieren der inhomogenen lichtverteilung eines laserstrahllichtbündels |
| EP0435826A1 (de) * | 1989-12-27 | 1991-07-03 | Ciba-Geigy Ag | Intravenöse Lösungen für Status Epilepticus |
| US5284662A (en) * | 1990-10-01 | 1994-02-08 | Ciba-Geigy Corp. | Oral osmotic system for slightly soluble active agents |
| RU2020972C1 (ru) * | 1991-02-07 | 1994-10-15 | Мегдятов Рашид Салехович | Способ лечения невралгии тройничного нерва |
| US5231089A (en) * | 1991-12-02 | 1993-07-27 | University Of Florida | Method of improving oral bioavailability of carbamazepine |
| FR2702148B1 (fr) | 1993-03-05 | 1995-04-07 | Rhone Poulenc Rorer Sa | Application d'anticonvulsivants dans le traitement du neuro-sida. |
| US5472714A (en) * | 1993-09-08 | 1995-12-05 | Ciba-Geigy Corporation | Double-layered oxcarbazepine tablets |
| US5466683A (en) | 1994-08-25 | 1995-11-14 | Teva Pharmaceutical Industries Ltd. | Water-soluble analogs of carbamazepine |
-
1997
- 1997-10-09 GB GBGB9721497.7A patent/GB9721497D0/en not_active Ceased
-
1998
- 1998-09-17 TW TW087115501A patent/TW584563B/zh not_active IP Right Cessation
- 1998-10-05 CO CO98057677A patent/CO4950520A1/es unknown
- 1998-10-05 CO CO98057677D patent/CO5090854A1/es unknown
- 1998-10-07 KR KR1020007003210A patent/KR100760326B1/ko not_active Expired - Fee Related
- 1998-10-07 EP EP98950110A patent/EP1033988B1/en not_active Expired - Lifetime
- 1998-10-07 SK SK505-2000A patent/SK286253B6/sk not_active IP Right Cessation
- 1998-10-07 WO PCT/EP1998/006382 patent/WO1999018966A1/en not_active Ceased
- 1998-10-07 PE PE1998000950A patent/PE121998A1/es not_active Application Discontinuation
- 1998-10-07 AU AU96298/98A patent/AU748034B2/en not_active Ceased
- 1998-10-07 CZ CZ20001279A patent/CZ298900B6/cs not_active IP Right Cessation
- 1998-10-07 ID IDW20000588A patent/ID24134A/id unknown
- 1998-10-07 RU RU2000110741/15A patent/RU2242231C2/ru not_active IP Right Cessation
- 1998-10-07 JP JP2000515601A patent/JP2001519395A/ja not_active Withdrawn
- 1998-10-07 NZ NZ503526A patent/NZ503526A/xx unknown
- 1998-10-07 PL PL339446A patent/PL192287B1/pl not_active IP Right Cessation
- 1998-10-07 CA CA002304661A patent/CA2304661C/en not_active Expired - Fee Related
- 1998-10-07 MY MYPI98004586A patent/MY122129A/en unknown
- 1998-10-07 HU HU0004362A patent/HU226106B1/hu not_active IP Right Cessation
- 1998-10-07 ES ES98950110T patent/ES2214738T3/es not_active Expired - Lifetime
- 1998-10-07 BR BR9812861-2A patent/BR9812861A/pt not_active Application Discontinuation
- 1998-10-07 PT PT98950110T patent/PT1033988E/pt unknown
- 1998-10-07 DE DE69821024T patent/DE69821024T2/de not_active Expired - Lifetime
- 1998-10-07 US US09/509,973 patent/US6316417B1/en not_active Expired - Fee Related
- 1998-10-07 CN CNB988099888A patent/CN1210032C/zh not_active Expired - Fee Related
- 1998-10-07 TR TR2000/00870T patent/TR200000870T2/xx unknown
- 1998-10-07 DK DK98950110T patent/DK1033988T3/da active
- 1998-10-07 AT AT98950110T patent/ATE257383T1/de not_active IP Right Cessation
- 1998-10-07 AR ARP980105003A patent/AR015465A1/es unknown
- 1998-10-07 IL IL13512398A patent/IL135123A0/xx unknown
- 1998-10-08 ZA ZA989183A patent/ZA989183B/xx unknown
-
2000
- 2000-04-04 NO NO20001730A patent/NO327263B1/no not_active IP Right Cessation
-
2001
- 2001-11-09 US US10/037,090 patent/US6458770B1/en not_active Expired - Fee Related
-
2005
- 2005-05-06 JP JP2005135218A patent/JP2005281314A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7398836B2 (ja) | Ｒ－ケタミンおよびその塩の医薬品としての応用 | |
| ES2938560T3 (es) | Formulaciones de cannabinoides estables | |
| EP3329909B1 (en) | Fenfluramine for use in the treatment of dravet syndrome | |
| Versiani et al. | Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients | |
| US9125898B2 (en) | Acetam derivatives for pain relief | |
| JP2009531435A (ja) | うつ病の治療用の新規な治療組み合わせ | |
| LU81294A1 (fr) | Procede pour causer de l'anorecie par administration buccale de naltrexone ou d'un sel de celle-ci | |
| JP2009514929A (ja) | 閉経前の性的欲求障害の治療のためのフリバンセリンの使用 | |
| JP2014500246A5 (https=) | ||
| JP2011504474A5 (https=) | ||
| JP5409602B2 (ja) | 慢性疼痛の治療におけるジミラセタムの使用 | |
| JP2007517049A (ja) | 再発性病状を治療するための組成物および方法 | |
| CN106714790A (zh) | 使用β肾上腺素能受体拮抗剂和毒蕈碱受体拮抗剂组合的治疗惊恐和焦虑症状的药物组合物和方法 | |
| JP2002527474A (ja) | 躁病および双極性障害の治療法 | |
| JP3905386B2 (ja) | 肥大を伴う心筋疾患の治療における徐脈剤の使用及び新規医薬組成物 | |
| JP2008509224A5 (https=) | ||
| ES2426008T5 (es) | Tratamiento de síntomas de la enfermedad de Parkinson con ligandos del receptor de histamina H3 de alquilaminas no imidazólicas | |
| JP2003535110A5 (https=) | ||
| TW202345851A (zh) | 治療方法 | |
| JP2005281314A5 (https=) | ||
| HUP0102456A2 (hu) | Valproesav analógok alkalmazása migrén és affektív betegségek kezelésére és megelőzésére | |
| CN1767834A (zh) | 10－羟基－10,11－二氢卡马西平衍生物用于治疗情感障碍的用途 | |
| JP2025510082A (ja) | 経鼻オランザピン製剤およびその使用方法 | |
| JPH03170475A (ja) | 抑うつ症治療剤 | |
| ES2366570T3 (es) | Asociación de un inhibidor de la corriente if sinusal y de un inhibidor de la enzima de conversión de la angiotensina. |